"CHICAGO (Reuters) - Genetic factors may help reveal which multiple sclerosis patients are likely to benefit from a widely used therapy and explain why some are not helped, according to a report published on Monday.
The treatment involved uses a protein known as recombinant interferon beta to try to treat multiple sclerosis symptoms and perhaps slow the course of the disease, for which there is no known cure."
To view this entire article, please click the title above.
No comments:
Post a Comment